Literature DB >> 18814120

Surgical treatment of lesions involving the supplementary motor area: clinical results of 12 patients.

Mustafa Onur Ulu1, Necmettin Tanriöver, Fatma Ozlen, Galip Zihni Sanus, Taner Tanriverdi, Ciğdem Ozkara, Mustafa Uzan.   

Abstract

AIM: Surgical resection of lesions involving the dominant supplementary motor area (SMA) may result in immediate postoperative motor and speech deficits which in most cases are reversible.We report 12 patients with frontal lesions involving the SMA and aim to analyse the clinical data and the correlation of neurological deficit with the extent of SMA resection.
MATERIAL AND METHODS: 12 patients (5M/7F, mean age 30.5) harbouring lesions involving the SMA who underwent surgery between 2002-2007 were evaluated retrospectively. Eloquent cortical areas were determined by functional MRI studies and/or invasive monitoring with subdural grids and depth electrodes and/or awake craniotomy with continuous intraoperative monitoring.
RESULTS: The evaluation of postoperative MRI's revealed total and subtotal resection of the lesion in 9(75%) and 3(25%) patients respectively. The extent of SMA resection was complete in 5 patients (41,6%) and incomplete in 7 patients (58,3%). Immediately postoperatively, all patients where the resection of SMA was complete displayed the typical characteristics of SMA syndrome. The degree of deficits was consistent with the extent of the SMA resection in all patients.
CONCLUSION: Proper diagnostic methods aiming to localise the sensorimotor area can minimize the risk of deficit in the surgical treatment of SMA lesions. The results suggest a relationship between the incidence of SMA syndrome and the extent of SMA resection.

Entities:  

Mesh:

Year:  2008        PMID: 18814120

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  8 in total

1.  Brain activation-based sexual orientation in female-to-male transsexuals.

Authors:  T-H Kim; G-W Kim; S-K Kim; G-W Jeong
Journal:  Int J Impot Res       Date:  2015-11-19       Impact factor: 2.896

2.  Postoperative supplementary motor area syndrome: clinical evolution and prognosis in nine patients after left hemispheric tumor resection.

Authors:  T Shamov; J Al-Hashel; R T Rousseff
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

Review 3.  Postoperative isolated lower extremity supplementary motor area syndrome: case report and review of the literature.

Authors:  Nardin Samuel; Brian Hanak; Jerry Ku; Ali Moghaddamjou; Francois Mathieu; Mahendra Moharir; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2019-11-09       Impact factor: 1.475

4.  Recurrent Supplementary Motor Area Syndrome Following Repeat Brain Tumor Resection Involving Supplementary Motor Cortex.

Authors:  Taylor J Abel; Robert T Buckley; Ryan P Morton; Patrik Gabikian; Daniel L Silbergeld
Journal:  Neurosurgery       Date:  2015-09       Impact factor: 4.654

5.  Resection frequency map after awake resective surgery for non-lesional neocortical epilepsy involving eloquent areas.

Authors:  Young-Hoon Kim; Chi Heon Kim; June Sic Kim; Sang Kun Lee; Chun Kee Chung
Journal:  Acta Neurochir (Wien)       Date:  2011-07-06       Impact factor: 2.216

6.  Insights from the supplementary motor area syndrome in balancing movement initiation and inhibition.

Authors:  A R E Potgieser; B M de Jong; M Wagemakers; E W Hoving; R J M Groen
Journal:  Front Hum Neurosci       Date:  2014-11-28       Impact factor: 3.169

7.  Intraoperative Motor Symptoms during Brain Tumor Resection in the Supplementary Motor Area (SMA) without Positive Mapping during Awake Surgery.

Authors:  Riho Nakajima; Mitsutoshi Nakada; Katsuyoshi Miyashita; Masashi Kinoshita; Hirokazu Okita; Tetsutaro Yahata; Yutaka Hayashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-04-28       Impact factor: 1.742

8.  Working Memory Deficits After Lesions Involving the Supplementary Motor Area.

Authors:  Alba Cañas; Montserrat Juncadella; Ruth Lau; Andreu Gabarrós; Mireia Hernández
Journal:  Front Psychol       Date:  2018-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.